出版应用/物种/样本/稀释 | 参考文献 |
---|
| Okato A, Goto Y, Kurozumi A, Kato M, Kojima S, Matsushita R, et al. Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer. Int J Oncol. 2016;49:111-22 pubmed 出版商
|
- 免疫组化-石蜡切片; 小鼠; 图 s3
- 免疫组化-石蜡切片; 人类; 图 1
| Fu Y, Cruz Monserrate Z, Helen Lin H, Chung Y, Ji B, Lin S, et al. Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype. Sci Rep. 2015;5:13347 pubmed 出版商
|
| Nilsen T, Thorsen L, FossÃ¥ S, Wiig M, Kirkegaard C, Skovlund E, et al. Effects of strength training on muscle cellular outcomes in prostate cancer patients on androgen deprivation therapy. Scand J Med Sci Sports. 2016;26:1026-35 pubmed 出版商
|
| Kounatidou E, Nakjang S, McCracken S, Dehm S, Robson C, Jones D, et al. A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. Nucleic Acids Res. 2019;47:5634-5647 pubmed 出版商
|
| Hao Y, Bjerke G, Pietrzak K, Melhuish T, Han Y, Turner S, et al. TGFβ signaling limits lineage plasticity in prostate cancer. PLoS Genet. 2018;14:e1007409 pubmed 出版商
|
| Cortes C, Ling S, Guo L, Hung G, Tsunemi T, Ly L, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82:295-307 pubmed 出版商
|
| Wu J, Liu J, Jia R, Song H. Nur77 inhibits androgen-induced bladder cancer growth. Cancer Invest. 2013;31:654-60 pubmed 出版商
|
| Reis B, Jungbluth A, Frosina D, Holz M, Ritter E, Nakayama E, et al. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res. 2013;19:6112-25 pubmed 出版商
|
| Zhou J, Richardson M, Reddy V, Menon M, Barrack E, Reddy G, et al. Structural and functional association of androgen receptor with telomeres in prostate cancer cells. Aging (Albany NY). 2013;5:3-17 pubmed
|
| Gan L, He J, Zhang X, Zhang Y, Yu G, Chen Y, et al. Expression profile and prognostic role of sex hormone receptors in gastric cancer. BMC Cancer. 2012;12:566 pubmed 出版商
|
| Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, et al. FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. PLoS ONE. 2012;7:e42456 pubmed 出版商
|
| O CONNELL K, Prencipe M, O Neill A, Corcoran C, Rani S, Henry M, et al. The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines. Proteomics. 2012;12:2115-26 pubmed 出版商
|